Characterization Imaging Instruments in Alcoholics and Non-Alcoholics
Launched by NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM (NIAAA) · Apr 8, 2014
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the differences in brain structure and behavior between people who are dependent on alcohol and those who are not. Researchers want to understand how these differences might relate to a person’s personality and behavior. The goal is to gain insights that could help in treating alcohol-related disorders.
To participate, you need to be at least 18 years old and willing to undergo a series of assessments, including a medical history review, urine and blood tests, and a psychiatric interview to evaluate your alcohol use. If qualified, you'll take part in some computerized games while lying in an MRI scanner, which uses strong magnets to take detailed pictures of your brain. The entire visit will take place at the NIH Clinical Center and will last about 90 minutes, with some time spent inside the scanner. Remember, if you have any conditions that would make lying still or being in a closed space uncomfortable, or if you are pregnant, you may not be eligible for this study.
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- All adult participants must be:
- • Age 18 years or older,
- • Have been pre-screened, determined eligible for any NIAAA study, or enrolled in any
- • NIAAA study (including 14-AA-0181).
- EXCLUSION CRITERIA:
- • As this is a natural history protocol, there are no exclusionary criteria for this study.
- • Participants should have been tested negative at the time of consent and study procedures using an alcohol breathalyzer, urine drug (UDT) and, when applicable, pregnancy tests. Individuals with a positive breath alcohol concentration (BrAC), UDT, or pregnancy test will be rescheduled or withdrawn from the study.
- • Upon completion of the consent, the participant will be invited for the study session. On the study session day, the following exclusion criteria will be applied.
- • -Exclusion criteria for MR scan\*
- • Positive BrAC#,
- • Positive urine drug test (UDT) # for benzodiazepines, cocaine, methamphetamines, opiates and tetrahydrocannabinol (THC) for outpatients. Positive UDT for benzodiazepines and THC are not exclusionary for the inpatients. It is common that the inpatients who are treated for AUD withdrawal are treated with benzodiazepines. Positive THC would also not be exclusionary for this study since it tends to be detected over the long period of time after use. However, we will make note of these for the data analysis purposes.
- • Task performance (behavioral, fMRI) only: cleared based on neuromotor examination,
- • Presence of ferromagnetic objects in the body that are contraindicated for MRI of the head (pacemakers or other implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips, metallic prostheses, permanent eyeliner, implanted delivery pump, or shrapnel fragments),
- • Cannot lie comfortably flat on back for up to 2 hours in the MRI scanner,
- • Uncomfortable in enclosed spaces (has claustrophobia) such that they would feel discomfort in the scanner,
- • Women: are pregnant#,
- • Are left-handed.
- • Inpatient participants with alcohol use disorder who have symptoms of alcohol withdrawal as indicated by the most recent measurement within the past 30 days, measured by the Clinical Institute Withdrawal Assessment (CIWA-Ar) score \> 8.
- • Subjects excluded from MR scan may still perform the behavioral tasks which would otherwise be performed in the scanner, if they qualify for behavioral tasks. To avoid undue discomfort, burden, and inconvenience this information, if available, can be gathered from routine clinical care or other NIAAA clinical studies and data.
- • Participants who meet this exclusion criterion will not participate in any part of this study at the time. They will be re-scheduled for a future date(s) when they do not meet any of the exclusionary criterion.
About National Institute On Alcohol Abuse And Alcoholism (Niaaa)
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) is a leading federal agency dedicated to advancing research on alcohol-related health issues and fostering a deeper understanding of alcohol use disorders. As part of the National Institutes of Health (NIH), NIAAA supports a diverse portfolio of clinical trials aimed at developing innovative prevention and treatment strategies for alcohol abuse and dependence. By collaborating with researchers, healthcare providers, and community organizations, NIAAA strives to translate scientific findings into effective public health initiatives, ultimately aiming to reduce the impact of alcohol on individuals and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Bethesda, Maryland, United States
Patients applied
Trial Officials
Abdolreza Momenan, Ph.D.
Principal Investigator
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials